Thread by @SmartSyncServ

PIRAMAL ENTERPRISES DEMERGER ANNOUNCEMENT & CONCALL HIGHLIGHTS

Here we will cover the details of the proposed demerger of PEL and the details of the demerger concall.

1/ Division of PEL

~Division to create 2 completely separate business entities
~Unlock Value for Minority Shareholders

2/ Piramal Pharma Limited

~All pharma businesses and subsidiaries to come under PPL
~Each shareholder of PEL will get 4 shares of PPL

3/ Piramal Enterprises (Post Demerger)

~PHL Fininvest to be amalgamated with PEL
~The merged HFC post DHFL acquisition to be a wholly-owned subsidiary of PEL

4/ Current Corporate Structure of PEL

5/ Post Demerger Corporate Structure of PEL & PPL

6/ Preparations done for The Demerger

~Strengthened & Deleveraged the Balance Sheet
~Raised funds for Piramal Pharma from Carlyle
~Completed DHFL acquisition

7/ Strategic Rationale for the demerger

~Simplify and optimize capital structure
~Promote independence of the 2 business lines
~Value unlocking for minority shareholders

8/ Piramal Enterprises (Post Demerger)

~Focusing on financial services only
~Looking to expand in the housing finance space with PCHFL
~Will look to achieve retail & wholesale lending ratio of 50:50 in the near term

9/ Piramal Pharma Limited

~Focus on bringing all pharma businesses under 1 banner
~Pursue both organic and inorganic growth

10/ Demerger Conference Call Highlights

If you find this thread valuable,
Please Like & Retweet